407 related articles for article (PubMed ID: 17475975)
1. Dynamic threshold for radiation target volume by PET/CT.
Wong CY; Mahajan P; Yan D
J Nucl Med; 2007 May; 48(5):849; author reply 847. PubMed ID: 17475975
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET in planning radiation treatment of non-small cell lung cancer: where exactly is the tumor?
Dahele MR; Ung YC
J Nucl Med; 2007 Aug; 48(8):1402; author reply 1403. PubMed ID: 17673427
[No Abstract] [Full Text] [Related]
4. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
[TBL] [Abstract][Full Text] [Related]
5. PET and PET-CT in radiation treatment planning for lung cancer.
Aristei C; Falcinelli L; Palumbo B; Tarducci R
Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922
[TBL] [Abstract][Full Text] [Related]
6. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
7. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
[TBL] [Abstract][Full Text] [Related]
8. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer.
Shi W; Liu C; Lu B; Yeung A; Newlin HE; Amdur RJ; Olivier KR
Am J Clin Oncol; 2010 Apr; 33(2):153-6. PubMed ID: 19806038
[TBL] [Abstract][Full Text] [Related]
12. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of PET-CT data for radiotherapy planning: what are we looking for?
Chiti A; Kirienko M; Grégoire V
Radiother Oncol; 2010 Sep; 96(3):277-9. PubMed ID: 20727607
[No Abstract] [Full Text] [Related]
14. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer.
Bradley JD; Perez CA; Dehdashti F; Siegel BA
J Nucl Med; 2004 Jan; 45 Suppl 1():96S-101S. PubMed ID: 14736840
[TBL] [Abstract][Full Text] [Related]
15. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
16. Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning.
Davis JB; Reiner B; Huser M; Burger C; Székely G; Ciernik IF
Radiother Oncol; 2006 Jul; 80(1):43-50. PubMed ID: 16876272
[TBL] [Abstract][Full Text] [Related]
17. Critical review of PET-CT for radiotherapy planning in lung cancer.
Senan S; De Ruysscher D
Crit Rev Oncol Hematol; 2005 Dec; 56(3):345-51. PubMed ID: 15990331
[TBL] [Abstract][Full Text] [Related]
18. Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer.
Everitt C; Leong T
Australas Radiol; 2006 Jun; 50(3):271-4. PubMed ID: 16732830
[TBL] [Abstract][Full Text] [Related]
19. How do we best balance optimal timing of FDG PET-CT imaging?
Hofman MS; O'Doherty M
Nucl Med Commun; 2007 Dec; 28(12):885-7. PubMed ID: 18090212
[No Abstract] [Full Text] [Related]
20. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
